Clonidine is a centrally acting alpha-2 adrenergic agonist primarily used to treat hypertension, attention deficit hyperactivity disorder (ADHD), and symptoms associated with drug withdrawal. As pharmaceutical… Read more









![Chemical structure of 2-[(E)-2,6-Dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2519452-56-1-2-E-26-Dichlorophenylimino-1-1-2-E-26-dichlorophenylimino-imidazolidin-1-yl-ethyl-imidazolidine.png&w=3840&q=75)



















![Chemical structure of Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino] (1140429)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FClonidine-Related-Compound-B-2-E-26-dichlorophenylimino-1-1-2-E-26-dichlorophenylimino-1140429.png&w=3840&q=75)

















Clonidine is a centrally acting alpha-2 adrenergic agonist primarily used to treat hypertension, attention deficit hyperactivity disorder (ADHD), and symptoms associated with drug withdrawal. As pharmaceutical laboratories work to ensure the safety and efficacy of this medication, they rely on high-quality reference standards for rigorous analytical testing. This category contains a comprehensive selection of Clonidine-related compounds, including pharmacopeial and non-pharmacopeial impurities, degradation products, and synthetic intermediates. These materials are essential for impurity profiling, method validation, and stability testing, allowing researchers to accurately monitor potential contaminants. Furthermore, the inclusion of stable isotope labelled compounds provides critical internal standards for precise quantification during mass spectrometry-based quality control procedures. By utilizing these characterized standards, analysts can maintain compliance with regulatory guidelines throughout the drug development and manufacturing lifecycle.